Burjeel Holdings, a leading super-specialty healthcare services provider with a growing presence in Saudi Arabia, today announced the signing of a joint venture with Keralty, a multinational health organization based in Colombia.
The joint venture, AL KALMA, will make its debut in the Kingdom, leveraging the shift in the Saudi healthcare market towards a primary healthcare model. The alliance aims to enhance well-being throughout the value chain by promoting access to high-quality healthcare at an affordable cost.
AL KALMA, a name that signifies 'united for health and well-being', will consolidate a unique value-based healthcare model with specialized primary care centers, health risk management, and a new range of integrated mental health services, expecting to reach nearly 30 million patients over the next decade.
The strategic partnership combines the experience and knowledge of both groups for a rapid roll-out in the Middle East, with the potential to extend subsequently into North Africa. The collaboration aims to extend services beyond the region by evaluating each market and executing the strategy on a country-by-country basis.
Burjeel Holdings, with a strong presence in the Middle East, offers the highest standards of care through an integrated network of hospitals, medical centers, and pharmacies, focusing on highly complex and specialized services. It runs PhysioTherabia, a network of advanced physiotherapy, rehabilitation and wellness services across the Kingdom and announced the launch of two Day Surgery Centers in Riyadh. Keralty, with a track record of nearly five decades and operations in nine countries, including the US and Colombia, enters into this joint venture by leveraging the success of its healthcare model based on the prevention, detection, and management of health risks, as well as the control and care of diseases and dependency.
Dr Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, commented: “This partnership marks a significant milestone for us as we strive to provide better health for a diverse range of populations. Our unique model envisions comprehensive well-being, from prevention to control and care of disease in order to enhance services and patient outcomes on a local, personalized level. This approach will keep people healthier and out of hospitals, leading to a substantial shift in healthcare delivery.”
Joseba Grajales, President of Keralty, said: “We are delighted to partner with Burjeel Holdings to extend our distinctive healthcare model to new regions. This model, successfully scaled from Colombia to numerous countries, is continuously enriched by our collective experiences. We provide valuable feedback across all our activities, achieving outstanding results in enhancing the health and well-being of millions who trust us. This success stems from our deep understanding of their health, social, and community needs.”
The Agreement signing ceremony in Cartagena de Indias in Colombia was attended by Mohammed Abdullah bin Khater Al Shamsi, Ambassador of the United Arab Emirates to the Republic of Colombia, Dr. Shamsheer Vayalil, John Sunil, CEO of Burjeel Holdings, along with Joseba Grajales and Dr. Emilio Herrera, CHO of Keralty.
Through AL KALMA, Burjeel and Keralty demonstrate their commitment to improving global health by providing access to quality healthcare and fostering well-being, sustainability, and efficiency. The agreement signifies a meaningful collaboration, aiming to benefit millions of people worldwide.
